Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | LY3090106 | - | - | - | - | 1件: 53 53 💬 |
| 2 | LY3090106 - IV | - | - | - | - | 1件: 46 46 💬 |
| 3 | LY3090106 - SQ | - | - | - | - | 1件: 46 46 💬 |
| 4 | Tibulizumab (LY3090106) | 1件: Tibulizumab Tibulizumab | 1件: Tibulizumab
Tibulizumab
💬 | 2件: IL17A IL17A,TNFSF13B 💬 | 8件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 53 53 💬 |